Biotech CEO pleads guilty to COVID-19 securities fraud scheme
By SDCN Editor A California man pleaded guilty Friday to securities fraud, wire fraud, and obstruction of an official proceeding in connection with his scheme to defraud investors by making false and misleading statements about the purported development of a new, blood-based COVID-19 test, leading to millions of dollars in investor losses, federal prosecutors said….